3-Bromopyruvate-mediated MCT1-dependent metabolic perturbation sensitizes triple negative breast cancer cells to ionizing radiation
<br><strong>Background<br></strong> Triple negative breast cancer (TNBC) poses a serious clinical challenge as it is an aggressive form of the disease that lacks estrogen receptor, progesterone receptor, and ERBB2 (formerly HER2) gene amplification, which limits the treatment...
Main Authors: | Skaripa-Koukelli, I, Hauton, D, Walsby-Tickle, J, Thomas, E, Owen, J, Lakshminarayanan, A, Able, S, McCullagh, J, Carlisle, R, Vallis, K |
---|---|
Format: | Journal article |
Language: | English |
Published: |
BioMed Central
2021
|
Similar Items
-
3-Bromopyruvate-mediated MCT1-dependent metabolic perturbation sensitizes triple negative breast cancer cells to ionizing radiation
by: Irini Skaripa-Koukelli, et al.
Published: (2021-10-01) -
Towards the synthesis and delivery of a halogenated MCT1 substrate
by: Skaripa-Koukelli, Eirini
Published: (2019) -
111In-labelled polymeric nanoparticles incorporating a ruthenium-based radiosensitizer for EGFR-targeted combination therapy in oesophageal cancer cells
by: Gill, M, et al.
Published: (2018) -
Metabolomics data for: Altered glycolysis triggers impaired mitochondrial metabolism and mTORC1 activation in diabetic β-cells
by: Walsby-Tickle, J, et al.
Published: (2022) -
Analysis of oligonucleotides by hydrophilic interaction liquid chromatography coupled to negative ion electrospray ionization mass spectrometry.
by: Gong, L, et al.
Published: (2011)